A Phase 1b Study of Venetoclax and Alvocidib in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)

UCI-18-09
NCT03441555
Cancer - Myeloid and Monocytic Leukemia
Deepa Jeyakumar
Open
Treatment
Alvocidib, Venetoclax
Ib/II
Adult
Local

For information about cancer clinical trials at the UCI Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.